Surgery Partners, Inc. (SGRY) Rating Reiterated by KeyCorp
Surgery Partners, Inc. (NASDAQ:SGRY)‘s stock had its “hold” rating reissued by investment analysts at KeyCorp in a research note issued on Tuesday.
SGRY has been the topic of several other research reports. Bank of America Corporation cut their price objective on Surgery Partners from $23.00 to $19.00 and set a “buy” rating on the stock in a report on Monday, October 9th. Zacks Investment Research downgraded Surgery Partners from a “hold” rating to a “strong sell” rating in a report on Saturday, August 12th. Citigroup Inc. reaffirmed a “buy” rating and set a $17.00 target price (down from $28.00) on shares of Surgery Partners in a report on Friday, August 11th. Stifel Nicolaus downgraded Surgery Partners from a “hold” rating to a “sell” rating and cut their target price for the stock from $21.00 to $17.00 in a report on Wednesday, August 9th. Finally, BidaskClub downgraded Surgery Partners from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $19.29.
Shares of Surgery Partners (NASDAQ:SGRY) traded down 17.568% during trading on Tuesday, hitting $7.625. The stock had a trading volume of 1,103,659 shares. The stock has a market capitalization of $372.18 million, a price-to-earnings ratio of 50.164 and a beta of 2.05. The stock has a 50 day moving average price of $9.81 and a 200-day moving average price of $16.12. Surgery Partners has a one year low of $7.10 and a one year high of $24.05.
In other news, major shareholder H.I.G. Surgery Centers, Llc sold 26,455,651 shares of the business’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $19.00, for a total value of $502,657,369.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 7.60% of the stock is owned by insiders.
Several large investors have recently made changes to their positions in SGRY. Voya Investment Management LLC bought a new stake in Surgery Partners in the 2nd quarter valued at about $222,000. Royal Bank of Canada increased its position in Surgery Partners by 680.5% in the 2nd quarter. Royal Bank of Canada now owns 10,544 shares of the company’s stock valued at $240,000 after buying an additional 9,193 shares in the last quarter. Atria Investments LLC increased its position in Surgery Partners by 2.3% in the 2nd quarter. Atria Investments LLC now owns 10,627 shares of the company’s stock valued at $242,000 after buying an additional 238 shares in the last quarter. American International Group Inc. increased its position in Surgery Partners by 7.1% in the 1st quarter. American International Group Inc. now owns 11,462 shares of the company’s stock valued at $224,000 after buying an additional 759 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in Surgery Partners by 211.4% in the 2nd quarter. Russell Investments Group Ltd. now owns 11,915 shares of the company’s stock valued at $271,000 after buying an additional 8,089 shares in the last quarter. 39.17% of the stock is currently owned by institutional investors.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.